Your Team for Swiss Law – now also in Geneva

Search filters

Axpo spins its grid business off into a new group company

The Axpo Group produces, trades and distributes energy for more than 3 million People and several thousand companies in Switzerland and in over 30 countries throughout Europe. In order to better respond to market volatility, Axpo...

TOLREMO closes Series A financing of CHF 9 million

TOLREMO therapeutics AG, a privately held Swiss biotech company and ETH Zurich Spin-Off, completed a series A financing round of CHF 9.0 million. The round was led by BioMedPartners with Redalpine and Altos Venture as well as...

Berenberg sells a majority stake of Berenberg Bank (Schweiz) AG

The Hamburg based private bank Joh. Berenberg, Gossler & Co. KG sells a majority stake in its subsidiary Berenberg (Schweiz) AG to a group of well-known entrepreneurs and the local management. The transaction is subject to the...

China Medical System Holdings invests in VAXIMM

VAXIMM AG, a company focused on developing oral T-cell immunotherapies, entered into development and commercialization collaboration agreement with and received an equity investment by China Medical System Holdings Limited (CMS)...

CRISPR Therapeutics closes public offering of USD 200m

CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, announced on September 20, 2018 the pricing of a public offering of 4,210,526 of...

Novo REPAIR Impact Fund invests in Polyphor's antibiotic OMPTA pipeline

Novo REPAIR Impact Fund has committed to invest CHF 6.8M in Polyphor through a capital increase. In addition, the fund has committed to make a project-based, royalty-bearing investment of CHF 4.7M in cash at the achievements of...

Aspivix raises over CHF 1.8M in Series-A financing

Aspivix, the Swiss start-up innovating women’s care, focused on the development of non-traumatic and minimally invasive surgical instruments for gynecology, announces the successful closing of a Series-A financing round of over...

safe mountain SA sold to private investors

safe mountain SA, a start-up based at the École Hôtelière de Lausanne and owner of a certification method in the field of off-piste skiing and mountain sports, has been sold to private investors. VISCHER advised the selling...

ProteoMediX raised CHF 5.2 m in Series B Financing Round

ProteoMediX AG, a diagnostic company developing blood-based tests for the accurate diagnosis and prognosis of prostate cancer, successfully closed an equity financing round. The company raised CHF 5.2 mio. from existing investors....

Azafaros B.V. gets seed funding

Azafaros (www.azafaros.com), a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round....

You are currently offline. Some pages or content may fail to load.